Diversity in Dermatology Clinical Trials A Systematic Review

被引:102
作者
Charrow, Alexandra [1 ]
Di Xia, Fan [2 ]
Joyce, Cara [3 ]
Mostaghimi, Arash [4 ]
机构
[1] Harvard Med Sch, Harvard Combined Dermatol Residency Training Prog, Boston, MA USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[3] Walgreen Co, Deerfield, IL USA
[4] Harvard Med Sch, Dept Dermatol, Brigham & Womens Hosp, Boston, MA USA
关键词
RACE; CANCER; REPRESENTATION; ASSOCIATION; MINORITIES; SEX;
D O I
10.1001/jamadermatol.2016.4129
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
IMPORTANCE Though there have been significant shifts in US demographic data over the past 50 years, research cohorts lack full racial and ethnic representation. There is little data available regarding the diversity of dermatology research cohorts with respect to sex, race, and ethnicity. OBJECTIVE To characterize and assess the representation of racial and ethnic minorities and women in randomized controlled trials across a range of dermatologic conditions. EVIDENCE REVIEW All randomized clinical trials (RCTs) were identified between July 2010 and July 2015 within the PubMed database using the followingkeywords: "psoriasis," " atopic dermatitis," "acne," "vitiligo," "seborrheic dermatitis," "alopecia areata," and " lichen planus." Diverse study populations were defined as including a greater than 20% racial or ethnic minority participants based on US census data. The distributions of sex and race groups in studies were compared by journal type, disease type, and funding source. FINDINGS Of the 626 articles reporting RCTs included in this analysis, 532 (85.0%) reported the sex of study participants. Overall, 52 of 626 international (11.3%) studies and 58 of 97 studies (59.8%) conducted exclusively within the United States reported on the racial or ethnic demographics of study participants. Across all RCTs exclusively recruited within the United States that reported race, 74.4% of study participants were white. Disease type was significantly associated with the degree of racial diversity (P <.001) within a study cohort: 30.0% of US-based psoriasis had more than 20% racially or ethnically diverse research participants as compared with 73.9% of acne studies and 91.7% of eczema studies. CONCLUSION AND RELEVANCE Dermatologic clinical trials within the United States reflect the growing diversity of the US population. Reporting of both sex and racial/ethnic diversity of research cohorts is still lacking, especially among studies conducted outside of the United States.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 50 条
  • [41] Diversity of US participants in AstraZeneca-sponsored clinical trials
    Cabrera, Claudia
    Fernandez-Llaneza, Daniel
    Ghazoui, Zara
    D'Abrantes, Sofia
    Esparza-Franco, M. Alejandro
    Sopp, Charles
    Maj, Beata
    Chiou, Victoria L.
    Valastro, Barbara
    Pangalos, Menelas N.
    Galbraith, Susan
    Ghiorghiu, Serban
    Massacesi, Cristian
    CONTEMPORARY CLINICAL TRIALS, 2024, 140
  • [42] Participation of Women and Older Participants in Randomized Clinical Trials of Lipid-Lowering Therapies A Systematic Review
    Khan, Safi U.
    Khan, Muhammad Zia
    Subramanian, Charumathi Raghu
    Riaz, Haris
    Khan, Muhammad U.
    Lone, Ahmad Naeem
    Khan, Muhammad Shahzeb
    Benson, Eve-Marie
    Alkhouli, Mohamad
    Blaha, Michael J.
    Blumenthal, Roger S.
    Gulati, Martha
    Michos, Erin D.
    JAMA NETWORK OPEN, 2020, 3 (05)
  • [43] Diversity, Equity, and Inclusion in Clinical Trials
    Keegan, Grace
    Crown, Angelena
    Joseph, Kathie-Ann
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 32 (01) : 221 - 232
  • [44] Ensuring diversity in clinical trials: The role of clinical pharmacology
    Masters, Joanna C.
    Cook, Jack A.
    Anderson, Ginger
    Nucci, Gianluca
    Colzi, Anna
    Hellio, Marie-Pierre
    Corrigan, Brian
    CONTEMPORARY CLINICAL TRIALS, 2022, 118
  • [45] Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review
    Freudenburg, Elliott
    Bagheri, Iyla
    Srinivas, Sunay
    Martinez, Ariza
    Putluri, Nagireddy
    Klaassen, Zachary
    Kamat, Ashish M.
    Konety, Badrinath R.
    Kim, William Y.
    Dyrskjot, Lars
    McConkey, David J.
    Freedland, Stephen J.
    Black, Peter C.
    Daneshmand, Siamak
    Catto, James W. F.
    Williams, Stephen B.
    CANCER CAUSES & CONTROL, 2022, 33 (08) : 1071 - 1081
  • [46] Racial and ethnic disparities in Meniere's disease clinical trials: A systematic review
    Pearce, Alexa N.
    Farsi, Soroush
    Saadi, Carissa
    Speed, Olivia
    Dornhoffer, John
    Saadi, Robert A.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2025, 46 (01)
  • [47] Clinical significance in pediatric oncology randomized controlled treatment trials: a systematic review
    Howard, A. Fuchsia
    Goddard, Karen
    Rassekh, Shahrad Rod
    Samargandi, Osama A.
    Hasan, Haroon
    TRIALS, 2018, 19
  • [48] Defining Advanced Heart Failure: A Systematic Review of Criteria Used in Clinical Trials
    Bjork, Jonathan B.
    Alton, Kristina K.
    Georgiopoulou, Vasiliki V.
    Butler, Javed
    Kalogeropoulos, Andreas P.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (07) : 569 - 577
  • [49] Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review
    Rivoirard, Romain
    Langrand-Escure, Julien
    Oriol, Mathieu
    Tinquaut, Fabien
    Chauvin, Franck
    Rancoule, Chloe
    Magne, Nicolas
    Bourmaud, Aurelie
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 78 - 83
  • [50] Racial, Ethnic, and Sex Disparities in Nail Psoriasis Clinical Trials: A Systematic Review
    Ricardo, Jose W.
    Qiu, Yuqing
    Lipner, Shari R.
    SKIN APPENDAGE DISORDERS, 2022, 8 (03) : 171 - 178